Physician profile
Allison Koss
NPI 1265871412
$1,296.51
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.38 · 2021: $596 · 2022: $685.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.04 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $195.22 | 2022 | |
| Novo Nordisk INC | $188.08 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $171.44 | 2021 | |
| Glaxosmithkline, LLC. | $119.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $56.00 | 2022 | |
| Abbvie INC. | $55.73 | 2021-2022 | |
| Pfizer INC. | $52.71 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $44.18 | 2021-2022 | |
| Esperion Therapeutics, INC. | $41.70 | 2021-2022 | |
| Amarin Pharma, INC. | $19.08 | 2021 | |
| Daiichi Sankyo INC. | $18.63 | 2021 | |
| Mannkind Corporation | $18.22 | 2022 | |
| Redhill Biopharma INC. | $16.72 | 2022 | |
| Viiv Healthcare Company | $16.38 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.14 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.85 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.69 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.42 | 2022 | |
| Lilly USA, LLC | $12.61 | 2022 | |
| Astellas Pharma US INC | $11.72 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Koss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.